Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients

NCT03438773 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant; Complications
Kidney Transplant Failure and Rejection

Interventions

DRUG: Envarsus
DRUG: Tacrolimus

Sponsor

California Institute of Renal Research

Collaborators

[object Object]
[object Object]